AVTR Avantor, Inc. Common Stock
NYSE · Life Sciences Tools & Services · 在 SEC EDGAR 上查看 ↗ 收盘 十月 5, 2026 10-K/10-Q 七月 29, 2026
$15.43
· % 处于52周区间
· 高于低点
· 至高点
$7.2752周低点
$16.0552周高点
市值
$10.52B
P/E (TTM)
-18.4
EPS (TTM)
$-0.84
收入 (TTM)
$6.56B
AVTR 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$15.43
市值
$10.52B
P/E (TTM)
-18.4
EPS (TTM)
$-0.84
收入 (TTM)
$6.56B
ROE (TTM)
-9.7%
负债/权益 (MRQ)
0.7
52周区间
$7–$16
AVTR 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
关于 Avantor, Inc. Common Stock 公司概况（来自维基百科）
Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”.
History
The company's history traces back to 1904, when John Townsend Baker (1860–1935) founded the chemical company J.T. Baker specializing in producing chemically pure reagents. The company gained recognition for its "Baker Analyzed" labels, which provided detailed analyses of trace impurities in its products. In 1911, the company began publishing "The Chemist-Analyst," which promoted its products and philosophy. After Baker's death in 1935, the company was acquired by Vick Chemical Company in 1941. During World War II, J.T. Baker expanded its product line to include penicillin, pesticides, and chemicals for batteries and munitions. After the war, the company further diversified into high-purity solvents, chromatography columns, and hazardous waste spill kits. In 1985, J.T. Baker and its parent company Richardson-Vicks were sold to Procter & Gamble, and subsequently sold to Mallinckrodt in 1995.
In 2010, investment firm New Mountain Capital purchased Mallinckrodt Baker Inc., which then changed its name to Avantor. The company extended its international market with the 2011 acquisitions of the Indian laboratory reagents supplier RFCL and the Polish lab supply firm POCH.
In 2016, Avantor merged with Nusil Technology. In 2017, Avantor acquired chemical blending business Puritan Products Inc. and laboratory supplies company VWR. The combined company operates under the Avantor name, with VWR and vwr.com remaining as a selling channel.
In May 2019, Avantor went public with a $3.8 billion initial public offering, which gave the company a market capitalization of $7.62 billion. As of December 2023, the top shareholders of Avantor included Vanguard Group Inc., Dodge & Cox Inc., T. Rowe Price Investment Management Inc., and BlackRock Inc.
That same year the company expanded further into Asia with the opening of an innovation center in Shanghai, which focuses on monoclonal antibodies and cell and gene therapy. In 2020, Avantor doubled the size of its Bridgewater, New Jersey innovation center, expanding its research and development capabilities and cell and gene therapy reagent manufacturing.
In 2020, Avantor began providing services and raw materials to companies manufacturing vaccines and other therapies to fight the COVID-19 pandemic. Avantor added employees and extra shifts in order to increase capacity for producing synthetic lipids that are formed into nanoparticles, which carry mRNA into human cells.
In June 2021, Avantor acquired China-based RIM Bio, a manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications.
Through the acquisition, Avantor gained access to RIM's Changzhou, China facility, marking Avantor's first single-use production plant in the Africa, Middle East, Asia (AMEA) region. The deal is part of a larger expansion of the company's single-use manufacturing footprint with plans to increase its presence by 30%.
The company ranked 485th in 2023 and 506 in 2024 on the Fortune 500, based on its sales records.
Controversies
On August 26, 2020, Bloomberg News implicated Avantor and other companies in the U.S. opioid epidemic. According to Bloomberg, one of their compounds "acetic anhydride", was used illicitly by drug traffickers to convert crude opium into heroin. Bloomberg also found evidence that Avantor's compound was used in cartel drug labs, and that regulations implemented in 2018 didn't stop it from being widely available. In response, Avantor discontinued all sales of acetic anhydride in Mexico and destroyed its existing inventory. In 2021, Texas Senator John Cornyn, who serves on both the Judiciary Committee and the bipartisan Caucus on International Narcotics Control claims that Avantor should have known better, selling acetic anhydride within Mexico's unregulated market. What should have raised eyebrows as well is that it was sold in 18-liter containers, which is inconsistent with the ordinary use of acetic anhydride. Four other Republican senators also deplored Avantor's “apparent longstanding contribution to the opioid epidemic that killed 50,000 of our fellow citizens in 2019.”
来源：维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗
行业板块Healthcare
行业Life Sciences Tools & Services
员工13500
国家US
10年表现 收入、净利润、利润率和每股收益趋势
收入$6.55B2017-12-31 → 2025-12-31
EPS$-0.782018-12-31 → 2025-12-31
自由现金流$495M2019-12-31 → 2025-12-31
净利率-8.8%2019-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | AVTR | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -18.45年均值 ≈24.9 | ≈24.9 | · | · | |
| P/S | 1.65年均值 ≈2.2 | ≈2.2 | 3.7 | 低估 | |
| P/B (市净率) | 1.95年均值 ≈3.2 | ≈3.2 | 3.6 | 低估 | |
| EV / EBITDA (企业价值 / EBITDA) | -57.35年均值 ≈10.3 | ≈10.3 | · | · | |
| Price / FCF (股价/自由现金流) | 21.35年均值 ≈21.7 | ≈21.7 | · | · | |
| Price / Cash Flow (市现率) | 16.95年均值 ≈18.2 | ≈18.2 | 25.2 | 低估 | |
| EV / Revenue (市值/营收) | 2.25年均值 ≈2.9 | ≈2.9 | · | · | |
| EV / FCF (市值/自由现金流) | 28.55年均值 ≈28.9 | ≈28.9 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | AVTR | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 毛利率 (TTM) | 31.8%5年均值 ≈33.7% | ≈33.7% | 54.2% | 弱 | |
| 营业利润率 (TTM) | -4.6%5年均值 ≈10.1% | ≈10.1% | 9.2% | 低于平均水平 | |
| EBITDA Margin (息税折旧摊销前利润率) | -3.8%5年均值 ≈10.1% | ≈10.1% | 8.3% | 弱 | |
| 税前利润率 (TTM) | -7.2%5年均值 ≈6.7% | ≈6.7% | 5.9% | 低于平均水平 | |
| 净利润率 (TTM) | -8.8%5年均值 ≈4.8% | ≈4.8% | 2.4% | 持平 | |
| ROA (TTM) | -4.7%5年均值 ≈2.7% | ≈2.7% | -0.14% | 弱 | |
| ROE (TTM) | -9.7%5年均值 ≈7.6% | ≈7.6% | -0.40% | 弱 | |
| ROIC | -3.1%5年均值 ≈5.1% | ≈5.1% | 1.1% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | AVTR | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 负债/股东权益比率 (MRQ) | 0.75年均值 ≈1.1 | ≈1.1 | 0.7 | 持平 | |
| 流动比率 (MRQ) | 1.85年均值 ≈1.6 | ≈1.6 | 3.0 | 低流动性 | |
| Quick Ratio (速动比率) | 1.05年均值 ≈0.9 | ≈0.9 | 1.6 | 低于平均水平 | |
| 长期负债/股东权益 (MRQ) | 0.75年均值 ≈1.0 | ≈1.0 | 0.7 | 持平 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | AVTR | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | -3.4%5年均值 ≈0.78% | ≈0.78% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | -4.5%5年均值 ≈-1.4% | ≈-1.4% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 0.49% | · | · | · | |
| EPS YoY | 121.3%5年均值 ≈232.8% | ≈232.8% | · | · | |
| Net Income YoY (净利润同比增长) | 121.6%5年均值 ≈119.8% | ≈119.8% | · | · | |
| EPS CAGR 3Y (每股收益年复合增长率（3年）) | 7.0% | · | · | · | |
| Net Income CAGR 3Y (净利润年复合增长率（3年）) | 7.5% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | AVTR | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.55年均值 ≈0.6 | ≈0.6 | 0.5 | 持平 | |
| Inventory Turnover (库存周转率) | 5.75年均值 ≈5.7 | ≈5.7 | 2.5 | 顶尖 | |
| Receivables Turnover (应收账款周转率) | 6.25年均值 ≈6.2 | ≈6.2 | 5.7 | 顶尖 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$485.3K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.49%
下次报告
十月 27, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 七月 30, 2026 | $0.21 | $0.19 | 8.6% |
| 2026年3月31日 | $0.17 | $0.16 | 6.2% | |
| 2025年12月31日 | $0.22 | $0.22 | -0.36% | |
| 2025年9月30日 | $0.22 | $0.23 | -4.0% | |
| 2025年6月30日 | $0.24 | $0.25 | -5.1% | |
| 2025年3月31日 | $0.23 | $0.24 | -2.4% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.55B | $6.78B | $6.97B | $7.51B | $7.39B | $6.39B | $6.04B | $5.86B | $1.25B | |
| Cost of Revenue | $4.41B | $4.50B | $4.60B | $4.91B | $4.88B | $4.31B | $4.12B | $4.04B | $815M | |
| Gross Profit | $2.14B | $2.28B | $2.36B | $2.60B | $2.50B | $2.08B | $1.92B | $1.82B | $433M | |
| SG&A Expense | $1.60B | $1.64B | $1.51B | $1.47B | $1.53B | $1.37B | $1.37B | $1.41B | $450M | |
| Operating Income | $-246M | $1.08B | $696M | $1.13B | $972M | $707M | $552M | $414M | $-210M | |
| Interest Expense | · | · | $285M | $266M | $217M | $308M | $440M | $524M | $201M | |
| Interest Income | $42M | $75M | $65M | $16M | $2M | · | · | · | · | |
| Other Non-op | $-21M | $-1M | $6M | $-800.0K | $11M | $10M | $2M | $-4M | $8M | |
| Pretax Income | $-441M | $854M | $410M | $851M | $753M | $62M | $41M | $-114M | $-460M | |
| Income Tax | $89M | $142M | $89M | $165M | $180M | $-54M | $3M | $-27M | $-315M | |
| Net Income | $-530M | $712M | $321M | $686M | $573M | $117M | $38M | $-87M | $-113M | |
| EPS (Basic) | $-0.78 | $1.05 | $0.48 | $1.02 | $0.86 | $0.09 | $-0.84 | $-2.69 | · | |
| EPS (Diluted) | $-0.78 | $1.04 | $0.47 | $1.01 | $0.85 | $0.09 | $-0.84 | $-2.69 | · | |
| Shares (Basic) | 680,600,000 | 679,600,000 | 675,600,000 | 650,900,000 | 590,500,000 | 576,300,000 | 401,200,000 | 132,700,000 | · | |
| Shares (Diluted) | 680,600,000 | 681,900,000 | 678,400,000 | 679,400,000 | 599,600,000 | 583,400,000 | 401,200,000 | 132,700,000 | · | |
| EBITDA | $-246M | $1.08B | $696M | $1.13B | $972M | $707M | $552M | · | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $365M | $262M | $263M | $373M | $302M | $287M | $187M | $185M | · | |
| Receivables | $1.07B | $1.03B | $1.15B | $1.22B | $1.22B | $1.11B | $989M | $931M | · | |
| Inventory | $818M | $732M | $828M | $914M | $872M | $740M | $711M | $671M | · | |
| Other Current Assets | $193M | $119M | $144M | $153M | $81M | $91M | $135M | $113M | · | |
| Current Assets | $2.45B | $2.15B | $2.38B | $2.66B | $2.48B | $2.23B | $2.02B | $1.90B | · | |
| PP&E (Net) | $767M | $708M | $738M | $727M | $706M | $550M | $557M | $599M | · | |
| PP&E (Gross) | $1.51B | $1.34B | $1.35B | $1.25B | $1.15B | $938M | $865M | $824M | · | |
| Accum. Depreciation | $745M | $630M | $617M | $518M | $445M | $388M | $308M | $226M | · | |
| Goodwill | $4.99B | $5.54B | $5.72B | $5.65B | $5.34B | $2.86B | $2.77B | $2.78B | $2.85B | |
| Intangibles | $3.10B | $3.27B | $3.68B | $4.04B | $5.05B | $3.96B | $4.13B | $4.47B | · | |
| Other Non-current Assets | $396M | $360M | $358M | $294M | $233M | $217M | $205M | $63M | · | |
| Total Assets | $11.79B | $12.11B | $12.97B | $13.46B | $13.90B | $9.91B | $9.77B | $9.91B | · | |
| Accounts Payable | $742M | $663M | $626M | $758M | $755M | $679M | $560M | $557M | · | |
| Current Liabilities | $1.38B | $2.01B | $1.48B | $1.66B | $1.45B | $1.24B | $1.07B | $1.10B | · | |
| Capital Leases | $152M | $143M | $88M | $87M | $79M | · | $107M | · | · | |
| Deferred Tax | $557M | $557M | $613M | $731M | $913M | $724M | $785M | $908M | · | |
| Other Non-current Liabilities | $378M | $358M | $350M | $295M | $358M | $398M | $428M | $318M | · | |
| Total Liabilities | $6.23B | $6.16B | $7.72B | $8.61B | $9.70B | $7.23B | $7.31B | $9.10B | · | |
| Long-term Debt | $3.95B | $4.06B | $5.54B | $6.29B | $7.02B | $4.89B | $5.12B | $6.92B | · | |
| Total Debt | $3.95B | $4.06B | $5.54B | $6.29B | $7.02B | $4.89B | $5.12B | · | · | |
| Retained Earnings | $1.67B | $2.20B | $1.49B | $1.17B | $484M | $-89M | $-204M | $-238M | · | |
| Treasury Stock | $76M | $0 | · | · | · | · | · | · | · | |
| AOCI | $-17M | $-184M | $-69M | $-100M | $-43M | $22M | $-86M | $-66M | $26M | |
| Stockholders' Equity | $5.57B | $5.96B | $5.25B | $4.86B | $4.20B | $2.67B | $2.46B | $-3.05B | $-2.62B | |
| Liabilities + Equity | $11.79B | $12.11B | $12.97B | $13.46B | $13.90B | $9.91B | $9.77B | $9.91B | · | |
| Shares Outstanding | 682,000,000 | 680,800,000 | 676,600,000 | 674,300,000 | 609,700,000 | 580,100,000 | 572,800,000 | 132,800,000 | · |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $410M | $406M | $402M | $406M | $379M | $395M | $399M | $405M | $99M | |
| Stock-based Comp | $46M | $47M | $40M | $46M | $51M | $44M | $68M | $18M | $48M | |
| Deferred Tax | $8M | $-47M | $-172M | $-69M | $-18M | $-88M | $-107M | $-104M | $-431M | |
| Amort. of Intangibles | $301M | $300M | $308M | $318M | $291M | $308M | $312M | $321M | $65M | |
| Restructuring | $30M | $83M | $26M | $4M | $5M | $12M | $24M | $81M | $30M | |
| Operating Cash Flow | $624M | $841M | $870M | $844M | $954M | $930M | $354M | $200M | $-168M | |
| CapEx | $129M | $149M | $146M | $133M | $111M | $62M | $52M | $38M | $25M | |
| Investing Cash Flow | $-130M | $439M | $-144M | $-110M | $-4.12B | $-59M | $-42M | $-23M | $-6.68B | |
| Debt Issued | $1.11B | $0 | $0 | $327M | $2.83B | $3.94B | $1M | $36M | $9.25B | |
| Net Debt Issued | $-319M | $-1.34B | $-846M | $-620M | $2.30B | $-423M | $-1.88B | · | · | |
| Stock Issued | · | · | $0 | $0 | $967M | $0 | $4.24B | · | · | |
| Stock Repurchased | $75M | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | $-75M | · | $0 | $0 | $967M | · | · | · | · | |
| Financing Cash Flow | $-409M | $-1.28B | $-844M | $-649M | $3.22B | $-783M | $-308M | $-170M | $6.96B | |
| Net Change in Cash | $104M | $-23M | $-109M | $70M | $38M | $100M | $2M | $-800.0K | $122M | |
| Taxes Paid | $145M | $248M | $224M | $257M | $145M | $43M | $112M | $66M | $32M | |
| Free Cash Flow | $495M | $692M | $724M | $710M | $842M | $868M | $302M | · | · | |
| Levered FCF | · | · | $501M | $496M | $677M | $292M | $-107M | · | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 32.6% | 33.6% | 33.9% | 34.6% | 33.9% | 32.5% | 31.8% | · | · | |
| Operating Margin | -3.8% | 16.0% | 10.0% | 15.0% | 13.2% | 11.1% | 9.1% | · | · | |
| Net Margin | -8.1% | 10.5% | 4.6% | 9.1% | 7.8% | 1.8% | 0.63% | · | · | |
| Pretax Margin | -6.7% | 12.6% | 5.9% | 11.3% | 10.2% | 0.97% | 0.67% | · | · | |
| EBITDA Margin | -3.8% | 16.0% | 10.0% | 15.0% | 13.2% | 11.1% | 9.1% | · | · | |
| ROA | -4.4% | 5.7% | 2.4% | 5.0% | 4.8% | 1.2% | 0.38% | · | · | |
| ROE | -8.9% | 12.4% | 6.2% | 14.5% | 13.8% | 4.5% | 1.6% | · | · | |
| ROIC | -3.1% | 9.0% | 5.1% | 8.2% | 6.6% | 17.5% | 6.8% | · | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.1 | 1.6 | 1.6 | 1.7 | 1.8 | 1.9 | · | · | |
| Quick Ratio | 1.0 | 0.6 | 1.0 | 1.0 | 1.1 | 1.1 | 1.1 | · | · | |
| Debt / Equity | 0.7 | 0.7 | 1.1 | 1.3 | 1.7 | 1.8 | 2.1 | · | · | |
| LT Debt / Equity | 0.7 | 0.5 | 1.0 | 1.2 | 1.7 | 1.8 | 2.0 | · | · | |
| Interest Coverage | · | · | 2.4 | 4.3 | 4.5 | 2.3 | 1.3 | · | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | · | · | |
| Inventory Turnover | 5.7 | 5.8 | 5.3 | 5.5 | 6.1 | 5.9 | 6.0 | · | · | |
| Receivables Turnover | 6.2 | 6.2 | 5.9 | 6.2 | 6.3 | 6.1 | 6.3 | · | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.16 | $8.75 | $7.76 | $7.20 | $6.88 | $4.61 | $4.30 | · | · | |
| Revenue / Share | $9.63 | $9.95 | $10.27 | $11.06 | $12.32 | $10.96 | · | · | · | |
| Cash Flow / Share | $0.92 | $1.23 | $1.28 | $1.24 | $1.59 | $1.59 | · | · | · | |
| Cash / Share | $0.54 | $0.38 | $0.39 | $0.55 | $0.49 | $0.49 | $0.33 | · | · | |
| EPS (TTM) | $-0.78 | $1.04 | $0.47 | $1.01 | $0.85 | $0.09 | $-0.84 | · | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -3.4% | -2.6% | -7.3% | 1.7% | 15.5% | · | · | · | · | |
| Revenue CAGR 3Y | -4.5% | -2.8% | 2.9% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 0.49% | · | · | · | · | · | · | · | · | |
| EPS YoY | · | 121.3% | -53.5% | 18.8% | 844.4% | · | · | · | · | |
| EPS CAGR 3Y | · | 7.0% | 73.5% | · | · | · | · | · | · | |
| Net Income YoY | · | 121.6% | -53.2% | 19.9% | 391.1% | · | · | · | · | |
| Net Income CAGR 3Y | · | 7.5% | 40.2% | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.55B | $6.78B | $6.97B | $7.51B | $7.39B | $6.39B | $6.04B | · | · | |
| Net Income TTM | $-530M | $712M | $321M | $686M | $573M | $117M | $38M | · | · | |
| Market Cap | $7.82B | $14.34B | $15.45B | $14.22B | $25.69B | $16.33B | $10.40B | · | · | |
| Enterprise Value | $11.40B | $18.14B | $20.72B | $20.14B | $32.41B | $20.94B | $15.33B | · | · | |
| P/E | -14.7 | 20.3 | 48.6 | 20.9 | 49.6 | 312.8 | -21.6 | · | · | |
| P/S | 1.2 | 2.1 | 2.2 | 1.9 | 3.5 | 2.6 | 1.7 | · | · | |
| P/B | 1.4 | 2.4 | 2.9 | 2.9 | 6.1 | 6.1 | 4.2 | · | · | |
| P / Cash Flow | 12.5 | 17.1 | 17.8 | 16.9 | 26.9 | 17.6 | 29.4 | · | · | |
| P / FCF | 15.8 | 20.7 | 21.3 | 20.0 | 30.5 | 18.8 | 34.4 | · | · | |
| EV / EBITDA | -46.3 | 16.7 | 29.8 | 17.8 | 33.3 | 29.6 | 27.8 | · | · | |
| EV / FCF | 23.0 | 26.2 | 28.6 | 28.4 | 38.5 | 24.1 | 50.7 | · | · | |
| EV / Revenue | 1.7 | 2.7 | 3.0 | 2.7 | 4.4 | 3.3 | 2.5 | · | · | |
| Earnings Yield | -6.8% | 4.9% | 2.1% | 4.8% | 2.0% | 0.32% | -4.6% | · | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.69B | $1.58B | $1.66B | $1.62B | $1.68B | $1.58B | $1.69B | $1.71B | $1.70B | $1.68B | $1.72B | $1.72B | $1.74B | $1.78B | $1.79B | $1.86B | |
| Cost of Revenue | $1.16B | $1.08B | $1.14B | $1.10B | $1.13B | $1.05B | $1.12B | $1.15B | $1.12B | $1.11B | $1.15B | $1.14B | $1.15B | $1.16B | $1.18B | $1.21B | |
| Gross Profit | $537M | $501M | $524M | $526M | $554M | $535M | $563M | $564M | $582M | $570M | $570M | $579M | $590M | $625M | $614M | $651M | |
| SG&A Expense | $415M | $401M | $392M | $390M | $425M | $388M | $371M | $440M | $406M | $424M | $387M | $368M | $358M | $394M | $363M | $375M | |
| Operating Income | $122M | $100M | $126M | $-649M | $129M | $147M | $638M | $125M | $176M | $146M | $183M | $210M | $72M | $231M | $252M | $276M | |
| Interest Expense | $39M | $43M | · | $44M | $43M | $42M | · | $49M | $61M | $64M | · | $72M | $73M | $74M | · | $67M | |
| Interest Income | $10M | $10M | $11M | $12M | $11M | $8M | $12M | $27M | $18M | $18M | $18M | $17M | $16M | $14M | · | · | |
| Other Non-op | $-600.0K | $-500.0K | $-1M | $4M | $-4M | $-20M | $-5M | $700.0K | $2M | $1M | $2M | $700.0K | $2M | $600.0K | $-6M | $3M | |
| Pretax Income | $81M | $56M | $81M | $-690M | $82M | $86M | $584M | $74M | $115M | $81M | $120M | $136M | $-1M | $156M | $175M | $208M | |
| Income Tax | $43M | $12M | $28M | $22M | $17M | $21M | $84M | $17M | $22M | $20M | $21M | $28M | $6M | $34M | $33M | $41M | |
| Net Income | $38M | $43M | $52M | $-712M | $65M | $64M | $500M | $58M | $93M | $60M | $98M | $108M | $-7M | $122M | $142M | $167M | |
| EPS (Basic) | $0.06 | $0.06 | $0.08 | $-1.04 | $0.09 | $0.09 | $0.74 | $0.08 | $0.14 | $0.09 | $0.15 | $0.16 | $-0.01 | $0.18 | $0.20 | $0.25 | |
| EPS (Diluted) | $0.06 | $0.06 | $0.08 | $-1.04 | $0.09 | $0.09 | $0.73 | $0.08 | $0.14 | $0.09 | $0.14 | $0.16 | $-0.01 | $0.18 | $0.20 | $0.25 | |
| Shares (Basic) | 676,200,000 | 675,700,000 | · | 681,700,000 | 681,500,000 | 681,100,000 | · | 680,300,000 | 679,400,000 | 678,100,000 | · | 676,000,000 | 675,300,000 | 674,700,000 | · | 674,100,000 | |
| Shares (Diluted) | 677,200,000 | 676,800,000 | · | 681,700,000 | 681,800,000 | 682,400,000 | · | 683,000,000 | 682,600,000 | 681,400,000 | · | 678,500,000 | 675,300,000 | 678,100,000 | · | 679,300,000 | |
| EBITDA | $122M | $100M | · | $-649M | $129M | $147M | · | $125M | $176M | $146M | · | $210M | $72M | $231M | · | $276M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $307M | $279M | $365M | $252M | $449M | $316M | $262M | $285M | $273M | $235M | · | $237M | $236M | $295M | · | $266M | |
| Receivables | $1.14B | $1.10B | $1.07B | $1.08B | $1.15B | $1.10B | $1.03B | $1.09B | $1.13B | $1.13B | · | $1.15B | $1.22B | $1.28B | · | $1.23B | |
| Inventory | $829M | $810M | $818M | $796M | $780M | $750M | $732M | $780M | $796M | $811M | · | $850M | $890M | $904M | · | $905M | |
| Other Current Assets | $188M | $210M | $193M | $132M | $136M | $120M | $119M | $136M | $132M | $146M | · | $147M | $156M | $152M | · | $158M | |
| Current Assets | $2.46B | $2.40B | $2.45B | $2.26B | $2.51B | $2.28B | $2.15B | $2.50B | $2.33B | $2.32B | · | $2.38B | $2.50B | $2.63B | · | $2.56B | |
| PP&E (Net) | $772M | $766M | $767M | $762M | $759M | $736M | $708M | $723M | $754M | $740M | · | $698M | $698M | $736M | · | $698M | |
| PP&E (Gross) | · | · | $1.51B | · | · | · | $1.34B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $787M | $766M | $745M | $724M | $700M | $663M | $630M | $621M | $657M | $635M | · | $580M | $565M | $541M | · | $489M | |
| Goodwill | $4.94B | $4.95B | $4.99B | $4.98B | $5.76B | $5.61B | $5.54B | $5.67B | $5.66B | $5.67B | $5.72B | $5.64B | $5.69B | $5.68B | $5.65B | $5.51B | |
| Intangibles | $2.92B | $3.01B | $3.10B | $3.17B | $3.26B | $3.24B | $3.27B | $3.43B | $3.49B | $3.57B | · | $3.70B | $3.80B | $3.98B | · | $4.01B | |
| Other Non-current Assets | $412M | $442M | $396M | $406M | $391M | $368M | $360M | $420M | $368M | $368M | · | $289M | $277M | $272M | · | $245M | |
| Total Assets | $11.60B | $11.66B | $11.79B | $11.68B | $12.78B | $12.33B | $12.11B | $12.84B | $12.69B | $12.76B | · | $12.80B | $13.06B | $13.40B | · | $13.11B | |
| Accounts Payable | $743M | $736M | $742M | $692M | $709M | $680M | $663M | $674M | $657M | $573M | · | $656M | $687M | $766M | · | $769M | |
| Current Liabilities | $1.38B | $1.37B | $1.38B | $1.52B | $2.58B | $2.03B | $2.01B | $1.63B | $1.46B | $1.44B | · | $1.49B | $1.55B | $1.67B | · | $1.55B | |
| Capital Leases | · | · | $152M | · | · | · | $143M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $540M | $550M | $557M | $548M | $536M | $550M | $557M | $547M | $575M | $601M | · | $649M | $663M | $696M | · | $728M | |
| Other Non-current Liabilities | $383M | $377M | $378M | $403M | $391M | $365M | $358M | $419M | $362M | $361M | · | $271M | $269M | $300M | · | $334M | |
| Total Liabilities | $5.97B | $6.07B | $6.23B | $6.11B | $6.49B | $6.23B | $6.16B | $7.29B | $7.26B | $7.43B | · | $7.70B | $8.05B | $8.40B | · | $8.52B | |
| Long-term Debt | $3.70B | $3.82B | $3.95B | $3.86B | $4.24B | $4.11B | $4.06B | $4.92B | $5.12B | $5.32B | · | $5.63B | $5.88B | $6.06B | · | $6.19B | |
| Total Debt | $3.70B | $3.82B | · | $3.86B | $4.24B | $4.11B | · | $4.92B | $5.12B | $5.32B | · | $5.63B | $5.88B | $6.06B | · | $6.19B | |
| Retained Earnings | $1.75B | $1.72B | $1.67B | $1.62B | $2.33B | $2.27B | $2.20B | $1.70B | $1.64B | $1.55B | · | $1.39B | $1.28B | $1.29B | · | $1.03B | |
| Treasury Stock | $76M | $76M | $76M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| AOCI | $-55M | $-44M | $-17M | $-24M | $-10M | $-118M | $-184M | $-74M | $-107M | $-97M | · | $-111M | $-72M | $-90M | $-100M | $-212M | |
| Stockholders' Equity | $5.63B | $5.59B | $5.57B | $5.57B | $6.29B | $6.10B | $5.96B | $5.55B | $5.43B | $5.34B | $5.25B | $5.10B | $5.01B | $4.99B | $4.86B | $4.59B | |
| Liabilities + Equity | $11.60B | $11.66B | $11.79B | $11.68B | $12.78B | $12.33B | $12.11B | $12.84B | $12.69B | $12.76B | · | $12.80B | $13.06B | $13.40B | · | $13.11B | |
| Shares Outstanding | · | 682,900,000 | 682,000,000 | 681,900,000 | 681,600,000 | 681,500,000 | 680,800,000 | 680,600,000 | 679,600,000 | 679,200,000 | · | 676,300,000 | 675,700,000 | 675,100,000 | · | 674,200,000 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $106M | $105M | $103M | $104M | $103M | $100M | $101M | $102M | $103M | $100M | $101M | $98M | $103M | $101M | $101M | $101M | |
| Stock-based Comp | $15M | $9M | $11M | $7M | $16M | $12M | $11M | $12M | $11M | $13M | $9M | $10M | $9M | $13M | $10M | $12M | |
| Deferred Tax | $16M | $-10M | $50M | $-12M | $-18M | $-12M | $28M | $-23M | $-35M | $-18M | $-78M | $-29M | $-38M | $-26M | $-7M | $-22M | |
| Restructuring | · | · | $2M | $2M | · | · | $500.0K | $49M | · | · | $8M | $6M | $7M | $5M | $-200.0K | $1M | |
| Operating Cash Flow | $178M | $59M | $153M | $207M | $154M | $109M | $173M | $245M | $281M | $142M | $252M | $231M | $168M | $220M | $206M | $258M | |
| CapEx | $38M | $34M | $36M | $36M | $30M | $28M | $28M | $41M | $46M | $35M | $51M | $38M | $30M | $28M | $34M | $39M | |
| Investing Cash Flow | $-37M | $-33M | $-40M | $-33M | $-29M | $-29M | $558M | $-40M | $-45M | $-34M | $-50M | $-37M | $-29M | $-27M | $-33M | $4M | |
| Debt Issued | · | · | $1.04B | $68M | $0 | $0 | $0 | $-12M | $-29M | $41M | $0 | $0 | $0 | $0 | $82M | $35M | |
| Net Debt Issued | · | $-105M | · | · | · | $-31M | · | · | · | $-169M | · | · | · | $-270M | · | · | |
| Financing Cash Flow | $-112M | $-107M | $700.0K | $-370M | $-7M | $-34M | $-755M | $-199M | $-197M | $-130M | $-184M | $-188M | $-196M | $-275M | $-82M | $-219M | |
| Net Change in Cash | $28M | $-86M | $114M | $-198M | $134M | $54M | $-46M | $14M | $38M | $-28M | $27M | $-100.0K | $-58M | $-78M | $109M | $27M | |
| Taxes Paid | $30M | $10M | $29M | $22M | $77M | $17M | $120M | $42M | $69M | $17M | $29M | $69M | $113M | $14M | $75M | $51M | |
| Free Cash Flow | · | $25M | · | · | · | $81M | · | · | · | $107M | · | · | · | $192M | · | · | |
| Levered FCF | · | $-8M | · | · | · | $50M | · | · | · | $59M | · | · | · | $134M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.7% | 31.7% | · | 32.4% | 32.9% | 33.8% | · | 32.9% | 34.2% | 34.0% | · | 33.6% | 33.8% | 35.1% | · | 35.0% | |
| Operating Margin | 7.2% | 6.3% | · | -40.0% | 7.6% | 9.3% | · | 7.3% | 10.3% | 8.7% | · | 12.2% | 4.1% | 13.0% | · | 14.9% | |
| Net Margin | 2.2% | 2.7% | · | -43.8% | 3.8% | 4.1% | · | 3.4% | 5.5% | 3.6% | · | 6.3% | -0.42% | 6.8% | · | 9.0% | |
| Pretax Margin | 4.8% | 3.5% | · | -42.5% | 4.9% | 5.4% | · | 4.3% | 6.7% | 4.8% | · | 7.9% | -0.07% | 8.8% | · | 11.2% | |
| EBITDA Margin | 7.2% | 6.3% | · | -40.0% | 7.6% | 9.3% | · | 7.3% | 10.3% | 8.7% | · | 12.2% | 4.1% | 13.0% | · | 14.9% | |
| ROA | 0.31% | 0.36% | · | -5.8% | 0.51% | 0.51% | · | 0.45% | 0.72% | 0.46% | · | 0.84% | -0.06% | 0.89% | · | 1.3% | |
| ROE | 0.64% | 0.74% | · | -12.8% | 1.1% | 1.1% | · | 1.1% | 1.8% | 1.2% | · | 2.2% | -0.15% | 2.6% | · | 3.8% | |
| ROIC | 0.61% | 0.83% | · | -7.1% | 0.97% | 1.1% | · | 0.92% | 1.4% | 1.0% | · | 1.6% | 3.7% | 1.6% | · | 2.1% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.8 | · | 1.5 | 1.0 | 1.1 | · | 1.5 | 1.6 | 1.6 | · | 1.6 | 1.6 | 1.6 | · | 1.6 | |
| Quick Ratio | 1.0 | 1.0 | · | 0.9 | 0.6 | 0.7 | · | 0.8 | 1.0 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 1.0 | |
| Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.9 | 0.9 | 1.0 | · | 1.1 | 1.2 | 1.2 | · | 1.3 | |
| LT Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.5 | 0.5 | · | 0.8 | 0.9 | 0.9 | · | 1.0 | 1.1 | 1.1 | · | 1.3 | |
| Interest Coverage | 3.1 | 2.3 | · | -14.7 | 3.0 | 3.5 | · | 2.6 | 2.9 | 2.3 | · | 2.9 | 1.0 | 3.1 | · | 4.1 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 1.4 | 1.4 | · | 1.4 | 1.4 | 1.3 | · | 1.4 | 1.3 | 1.3 | · | 1.3 | 1.3 | 1.3 | · | 1.4 | |
| Receivables Turnover | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.5 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $8.18 | · | $8.17 | $9.22 | $8.95 | · | $8.16 | $8.00 | $7.86 | · | $7.54 | $7.42 | $7.40 | · | $6.81 | |
| Revenue / Share | $2.50 | $2.34 | · | $2.38 | $2.47 | $2.32 | · | $2.51 | $2.49 | $2.47 | · | $2.54 | $2.58 | $2.63 | · | $2.73 | |
| Cash Flow / Share | · | $0.09 | · | · | · | $0.16 | · | · | · | $0.21 | · | · | · | $0.32 | · | · | |
| Cash / Share | · | $0.41 | · | $0.37 | $0.66 | $0.46 | · | $0.42 | $0.40 | $0.35 | · | $0.35 | $0.35 | $0.44 | · | $0.39 | |
| EPS (TTM) | $-0.84 | $-0.81 | · | $-0.13 | $0.99 | $1.04 | · | $0.45 | $0.53 | $0.38 | · | $0.53 | $0.62 | $0.91 | · | $0.93 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.56B | $6.55B | · | $6.58B | $6.67B | $6.69B | · | $6.82B | $6.83B | $6.87B | · | $7.04B | $7.18B | $7.34B | · | $7.62B | |
| Net Income TTM | $-578M | $-551M | · | $-82M | $687M | $716M | · | $310M | $360M | $260M | · | $364M | $423M | $618M | · | $639M | |
| Market Cap | · | $5.35B | · | $8.51B | $9.17B | $11.05B | · | $17.61B | $14.41B | $17.37B | · | $14.26B | $13.88B | $14.27B | · | $13.21B | |
| Enterprise Value | · | $8.89B | · | $12.12B | $12.97B | $14.84B | · | $22.24B | $19.25B | $22.46B | · | $19.65B | $19.53B | $20.04B | · | $19.14B | |
| P/E | -11.8 | -9.7 | · | -96.0 | 13.6 | 15.6 | · | 57.5 | 40.0 | 67.3 | · | 39.8 | 33.1 | 23.2 | · | 21.1 | |
| P/S | · | 0.8 | · | 1.3 | 1.4 | 1.7 | · | 2.6 | 2.1 | 2.5 | · | 2.0 | 1.9 | 1.9 | · | 1.7 | |
| P/B | · | 1.0 | · | 1.5 | 1.5 | 1.8 | · | 3.2 | 2.7 | 3.3 | · | 2.8 | 2.8 | 2.9 | · | 2.9 | |
| P / Cash Flow | · | 91.2 | · | · | · | 101.1 | · | · | · | 122.6 | · | · | · | 65.0 | · | · | |
| EV / Revenue | · | 1.4 | · | 1.8 | 1.9 | 2.2 | · | 3.3 | 2.8 | 3.3 | · | 2.8 | 2.7 | 2.7 | · | 2.5 | |
| Earnings Yield | -8.5% | -10.3% | · | -1.0% | 7.4% | 6.4% | · | 1.7% | 2.5% | 1.5% | · | 2.5% | 3.0% | 4.3% | · | 4.7% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $6.55B | $6.78B | $6.97B | $7.51B | $7.39B |
| 毛利率 % | 32.6% | 33.6% | 33.9% | 34.6% | 33.9% |
| 营业利润率 % | -3.8% | 16.0% | 10.0% | 15.0% | 13.2% |
| 净收入 | $-530M | $712M | $321M | $686M | $573M |
| 稀释后每股收益 (EPS) | $-0.78 | $1.04 | $0.47 | $1.01 | $0.85 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.7 | 0.7 | 1.1 | 1.3 | 1.7 |
| 流动比率 | 1.8 | 1.1 | 1.6 | 1.6 | 1.7 |
| 速动比率 | 1.0 | 0.6 | 1.0 | 1.0 | 1.1 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $495M | $692M | $724M | $710M | $842M |
机构持有人 (13F) 493 家申报者 · $7.6B 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
493
持有价值
$7.6B
新仓位
97
已退出持仓
60
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 97 (-7 与上一季度对比) | 60 (-11 与上一季度对比) | 192 (+31 与上一季度对比) | 113 (-15 与上一季度对比) | +24.9M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| Dodge & Cox | $1188207643 | 120020974 | 15.59% | 股份 |
| VANGUARD GROUP INC | $743810028 | 64904889 | 9.76% | 股份 |
| BlackRock, Inc. | $695784194 | 70281231 | 9.13% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $310298175 | 31343250 | 4.07% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $304948067 | 30802835 | 4.00% | 股份 |
| GREENHAVEN ASSOCIATES INC | $243909369 | 24637310 | 3.20% | 股份 |
| STATE STREET CORP | $213572443 | 21572974 | 2.80% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $202086268 | 20412181 | 2.65% | 股份 |
| Engine Capital Management, LP | $196622217 | 19860830 | 2.58% | 股份 |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $195386083 | 19735968 | 2.56% | 股份 |
| New Mountain Capital, L.L.C. | $138600000 | 14000000 | 1.82% | 股份 |
| Invesco Ltd. | $137465065 | 13885360 | 1.80% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $130519321 | 13180567 | 1.71% | 股份 |
| MARSHALL WACE, LLP | $129988565 | 13130158 | 1.71% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $115112902 | 11627566 | 1.51% | 股份 |
| BANK OF AMERICA CORP /DE/ | $108794506 | 10989344 | 1.43% | 股份 |
| EARNEST PARTNERS LLC | $106410397 | 10748525 | 1.40% | 股份 |
| LONDON CO OF VIRGINIA | $103811008 | 10485960 | 1.36% | 股份 |
| FULLER & THALER ASSET MANAGEMENT, INC. | $101537816 | 10256345 | 1.33% | 股份 |
| D. E. Shaw & Co., Inc. | $94758077 | 9571523 | 1.24% | 股份 |
| First Pacific Advisors, LP | $81088326 | 8190740 | 1.06% | 股份 |
| SEI INVESTMENTS CO | $78677367 | 7947198 | 1.03% | 股份 |
| FMR LLC | $77670074 | 7845462 | 1.02% | 股份 |
| GENDELL JEFFREY L | $75311973 | 7607270 | 0.99% | 股份 |
| VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. | $73188967 | 7392825 | 0.96% | 股份 |
| Clarkston Capital Partners, LLC | $67214209 | 6789314 | 0.88% | 股份 |
| MORGAN STANLEY | $66905804 | 6758161 | 0.88% | 股份 |
| GOLDMAN SACHS GROUP INC | $61422976 | 6204341 | 0.81% | 股份 |
| NORGES BANK | $60307949 | 6091712 | 0.79% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $57627950 | 5821005 | 0.76% | 股份 |
| NORTHERN TRUST CORP | $56753512 | 5732678 | 0.74% | 股份 |
| Freestone Grove Partners LP | $56577352 | 5714884 | 0.74% | 股份 |
| UBS Group AG | $56155742 | 5672297 | 0.74% | 股份 |
| AMERIPRISE FINANCIAL INC | $54696928 | 5524942 | 0.72% | 股份 |
| YACKTMAN ASSET MANAGEMENT LP | $47223000 | 4770000 | 0.62% | 股份 |
| SOUTHEASTERN ASSET MANAGEMENT INC/TN/ | $46782232 | 4725478 | 0.61% | 股份 |
| Brickwood Asset Management LLP | $45515438 | 4597519 | 0.60% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $42790226 | 4322245 | 0.56% | 股份 |
| JONES FINANCIAL COMPANIES LLLP | $42363659 | 4120981 | 0.56% | 股份 |
| Bank of New York Mellon Corp | $40800098 | 4121222 | 0.54% | 股份 |
| ROYCE & ASSOCIATES LP | $36393232 | 3676084 | 0.48% | 股份 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $34719001 | 3506970 | 0.46% | 股份 |
| PRIVATE MANAGEMENT GROUP INC | $30662617 | 3097234 | 0.40% | 股份 |
| Voss Capital, LP | $26235000 | 2650000 | 0.34% | 股份 |
| Prescott General Partners LLC | $25740000 | 2600000 | 0.34% | 股份 |
| Gotham Asset Management, LLC | $24912796 | 2516444 | 0.33% | 股份 |
| Quantinno Capital Management LP | $24177175 | 2442138 | 0.32% | 股份 |
| KINNEY ASSET MANAGEMENT, LLC | $23025600 | 1845000 | 0.30% | 股份 |
| Loews Corp | $21780000 | 2200000 | 0.29% | 股份 |
| Western Standard LLC | $20888842 | 2109984 | 0.27% | 股份 |
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| The Goldman Sachs Group, Inc., Goldman Sachs & Co. LLC, Broad Street Principal Investments, L.L.C., Bridge Street Opportunity Advisors, L.L.C., StoneBridge 2017, L.P., StoneBridge 2017 Offshore, L.P., StoneBridge 2018, L.P., StoneBridge 2018 Offshore, L.P., VWR Partners, L.P. ×8 申报 | 2021年5月7日 | · | 初始申报 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 47 位内幕人士 · 29 位高管 · 20 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Emmanuel Ligner | President and CEO | 2026年8月18日 F | 737334 | 1 | 0 | $993125 |
| Michael Stubblefield | President & CEO | 2025年5月21日 G | 545500 | 0 | 0 | $0 |
| Todd W. Garner | EVP and CFO | 2026年9月21日 A | 49688 | 0 | 0 | $0 |
| Brent R. Jones | EVP, Chief Financial Officer | 2026年2月23日 F | 419782 | 0 | 0 | $0 |
| Thomas A Szlosek | EVP & CFO | 2023年5月17日 F | 77489 | 0 | 0 | $0 |
| Corey Walker | President, VWR Dist. & Servs. | 2026年6月21日 F | 384535 | 0 | 0 | $0 |
| Mary Blenn | EVP, Chief Operating Officer | 2026年2月19日 A | 253384 | 0 | 0 | $0 |
| Bjorn Hofman | EVP and COO | 2019年5月21日 A | 157143 | 0 | 0 | $0 |
| Brittany Hankamer | EVP, Chief HR Officer | 2026年8月14日 F | 248864 | 0 | 0 | $0 |
| Steven W Eck | SVP & Chief Accounting Officer | 2026年7月31日 F | 129593 | 0 | 0 | $0 |
| Claudius Sokenu | EVP, Chief Legal & Compliance | 2026年7月24日 F | 251228 | 0 | 0 | $0 |
| Ludovic Brellier | EVP, Bioscience & Medtech | 2026年5月1日 A | 146566 | 0 | 0 | $0 |
| Benoit Gourdier | EVP, Bioscience & Medtech | 2026年2月23日 F | 362859 | 0 | 0 | $0 |
| Christophe Couturier | EVP, AMEA | 2025年8月8日 A | 211271 | 0 | 0 | $0 |
| James Bramwell | EVP Sales, Customer Excellence | 2025年2月27日 S | 86605 | 0 | 0 | $0 |
| Kitty Sahin | EVP, Strategy&Corp Development | 2024年7月18日 F | 42274 | 0 | 0 | $0 |
| Randy Lee Stone | EVP, Laboratory Solutions | 2024年4月16日 F | 68105 | 0 | 0 | $0 |
| Sheri Lewis | EVP, Global Ops & Supply Chain | 2023年12月31日 F | 70692 | 0 | 0 | $0 |
| Frederic Vanderhaegen | EVP, Americas and Europe | 2023年8月25日 S | 160735 | 0 | 0 | $0 |
| Justin Miller | EVP & General Counsel | 2023年5月17日 F | 93336 | 0 | 0 | $0 |
| Gerard Brophy | EVP, Biopharma Production | 2023年5月17日 F | 89032 | 0 | 0 | $0 |
| Meghan Henson | EVP, Chief HR Officer | 2023年2月24日 A | 40184 | 0 | 0 | $0 |
| Michael Wondrasch | EVP & CIO | 2023年2月20日 F | 96072 | 0 | 0 | $0 |
| Mark Christopher Murray | EVP, Biomaterials & AT | 2022年1月13日 F | 18680 | 0 | 0 | $0 |
| Devashish Ohri | EVP, IMEA | 2021年5月27日 M | 139095 | 0 | 0 | $0 |
| Sven Henrichwark | EVP, APAC Region | 2021年2月25日 A | 19802 | 0 | 0 | $0 |
| Eric Mcallister | EVP, CHRO | 2020年5月17日 F | 197899 | 0 | 0 | $0 |
| Tanya Foxe | EVP, Operations & Supply Chain | 2020年2月21日 A | 39458 | 0 | 0 | $0 |
| Ashish Kulkarni | EVP and Chief Technology Officer | 2019年5月21日 A | 128571 | 0 | 0 | $0 |
| Gregory T Lucier | 董事 | 2026年5月8日 P | 60000 | 2 | 0 | $541200 |
| Simon Dingemans | 董事 | 2026年5月7日 A | 31495 | 1 | 0 | $203500 |
| Louise Makin | 董事 | 2026年5月7日 A | 47140 | 0 | 0 | $0 |
| Mala Murthy | 董事 | 2026年5月7日 A | 69479 | 0 | 0 | $0 |
| Michael Severino | 董事 | 2026年5月7日 A | 85821 | 0 | 0 | $0 |
| Joseph R Massaro | 董事 | 2026年5月7日 A | 77408 | 0 | 0 | $0 |
| Gregory L Summe | 董事 | 2026年5月7日 A | 83381 | 2 | 0 | $2065000 |
| Sanjeev K Mehra | 董事 | 2026年5月7日 A | 33376 | 2 | 0 | $4882750 |
| John Carethers | 董事 | 2025年5月8日 A | 45858 | 0 | 0 | $0 |
| Lan Kang | 董事 | 2025年5月8日 A | 52315 | 0 | 0 | $0 |
| Juan Andres | 董事 | 2025年5月8日 A | 65480 | 0 | 0 | $0 |
| Jonathan M Peacock | 董事 | 2025年5月8日 A | 219815 | 0 | 0 | $0 |
| Christi Shaw | 董事 | 2023年5月11日 A | 36271 | 0 | 0 | $0 |
| Matthew S. Holt | 董事 | 2022年5月12日 A | 7908 | 0 | 0 | $0 |
| Rajiv Gupta | 董事 | 2022年4月1日 A | 780562 | 0 | 0 | $0 |
| Jo Natauri | 董事 | 2021年7月12日 P | 557656 | 0 | 0 | $0 |
| Rakesh Sachdev | 董事 | 2021年2月25日 A | 32841 | 0 | 0 | $0 |
| Thomas Connolly | 董事 | 2020年6月18日 S | 72620082 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 56 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| LSEQ · Harbor ETF Trust | 2.52% | 27960 NS | 2026年7月31日 | N-PORT |
| EPSB · Harbor ETF Trust | 1.77% | 6133 NS | 2026年7月31日 | N-PORT |
| BSJS · Invesco Exchange-Traded Self-Inde... | 1.51% | 11851000 | 2026年10月2日 | 每日 |
| DFSV · Dimensional ETF Trust | 0.52% | 3118943 NS | 2026年7月31日 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0.40% | 25471 NS | 2026年7月31日 | N-PORT |
| IVOV · VANGUARD ADMIRAL FUNDS | 0.39% | 586296 SH | 2026年8月19日 | 每日 |
| QVMM · Invesco Exchange-Traded Fund Trus... | 0.32% | 88836 SH | 2026年10月2日 | 每日 |
| RWK · Invesco Exchange-Traded Fund Trus... | 0.27% | 230747 SH | 2026年10月2日 | 每日 |
| VFVA · VANGUARD WELLINGTON FUND | 0.27% | 233604 SH | 2026年8月19日 | 每日 |
| PTMC · Pacer Funds Trust | 0.27% | 75616 NS | 2026年7月31日 | N-PORT |
| NUSC · Nushares ETF Trust | 0.20% | 188520 NS | 2026年7月31日 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0.20% | 10027 NS | 2026年7月31日 | N-PORT |
| ESML · iShares Trust | 0.20% | 376218 SH | 2026年9月11日 | 每日 |
| BBMC · J.P. Morgan Exchange-Traded Fund ... | 0.19% | 286321 NS | 2026年7月31日 | N-PORT |
| IVOO · VANGUARD ADMIRAL FUNDS | 0.19% | 1104592 SH | 2026年8月19日 | 每日 |
| DFAT · Dimensional ETF Trust | 0.17% | 1765932 NS | 2026年7月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.17% | 1854609 NS | 2026年7月31日 | N-PORT |
| IYH · iShares Trust | 0.16% | 386410 SH | 2026年9月11日 | 每日 |
| VBR · VANGUARD INDEX FUNDS | 0.14% | 9920672 SH | 2026年8月19日 | 每日 |
| SMMD · iShares Trust | 0.14% | 351599 SH | 2026年9月11日 | 每日 |
| FHLC · FIDELITY COVINGTON TRUST | 0.13% | 313238 NS | 2026年7月31日 | N-PORT |
| REVS · Columbia ETF Trust I | 0.12% | 28653 NS | 2026年7月31日 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.10% | 1983361 SH | 2026年8月19日 | 每日 |
| IWS · iShares Trust | 0.10% | 978878 SH | 2026年9月11日 | 每日 |
| EQAL · Invesco Exchange-Traded Fund Trus... | 0.10% | 50803 SH | 2026年10月2日 | 每日 |
| WSML · iShares Trust | 0.09% | 41659 SH | 2026年9月11日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.08% | 7835858 SH | 2026年8月19日 | 每日 |
| VB · VANGUARD INDEX FUNDS | 0.08% | 15636784 SH | 2026年8月19日 | 每日 |
| TILT · FlexShares Trust | 0.08% | 121976 NS | 2026年7月31日 | N-PORT |
| RECS · Columbia ETF Trust I | 0.08% | 325274 NS | 2026年7月31日 | N-PORT |
| IWR · iShares Trust | 0.07% | 2700866 SH | 2026年9月11日 | 每日 |
| IUS · Invesco Exchange-Traded Self-Inde... | 0.06% | 37709 SH | 2026年10月2日 | 每日 |
| PRF · Invesco Exchange-Traded Fund Trust | 0.04% | 251941 SH | 2026年10月2日 | 每日 |
| IUSV · iShares Trust | 0.03% | 593664 SH | 2026年9月11日 | 每日 |
| DXUV · Dimensional ETF Trust | 0.03% | 11452 NS | 2026年7月31日 | N-PORT |
| IWD · iShares Trust | 0.03% | 1462438 SH | 2026年9月11日 | 每日 |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 397791 SH | 2026年8月19日 | 每日 |
| IYY · iShares Trust | 0.01% | 29349 SH | 2026年9月11日 | 每日 |
| IWB · iShares Trust | 0.01% | 457613 SH | 2026年9月11日 | 每日 |
| ITOT · iShares Trust | 0.01% | 885606 SH | 2026年9月11日 | 每日 |
| IWV · iShares Trust | 0.01% | 183968 SH | 2026年9月11日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.01% | 21681946 SH | 2026年8月19日 | 每日 |
| VT · VANGUARD INTERNATIONAL EQUITY IND... | 0.01% | 534809 SH | 2026年8月19日 | 每日 |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.01% | 109164 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.01% | 55632 SH | 2026年8月19日 | 每日 |
| ESGV · VANGUARD WORLD FUND | 0.01% | 149286 SH | 2026年8月19日 | 每日 |
| NEAR · iShares U.S. ETF Trust | 0.01% | 365000 SH | 2026年9月9日 | 每日 |
| DFUS · Dimensional ETF Trust | 0.00% | 5257 NS | 2026年7月31日 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 544 NS | 2026年7月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 1476 NS | 2026年7月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 2958 NS | 2026年7月31日 | N-PORT |
| IJH · iShares Trust | · | 23957709 SH | 2026年9月11日 | 每日 |
| IJJ · iShares Trust | · | 3487441 SH | 2026年8月31日 | 每日 |
| XJH · iShares Trust | · | 93400 SH | 2026年9月8日 | 每日 |
| ISCB · iShares Trust | · | 29420 SH | 2026年9月11日 | 每日 |
| ISCV · iShares Trust | · | 144718 SH | 2026年9月11日 | 每日 |
AVTR 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 25 位分析师
持有
中位数目标
$14.20
-7.9%
3 12.0%
强烈买入
5 20.0%
买入
16 64.0%
持有
1 4.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
14 位分析师 · 2026-10-05平均目标 $14.56 -5.6%
现在
当前价格 $15.43
最低$12.00
平均值$14.56
最高$19.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| AVTR | $7.82B | -14.7 | -3.4% | -8.1% | -8.9% | 32.6% |
| TEM | · | -41.9 | 83.4% | -19.3% | -61.2% | · |
| TEM | · | -41.9 | 83.4% | -19.3% | -61.2% | · |
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | · |
| TXG | $2.08B | -46.6 | 5.2% | -6.8% | -5.5% | 69.0% |
| TECH | $11.03B | 60.9 | -0.38% | 15.0% | 9.0% | 65.8% |
| RGEN | $9.23B | 190.5 | 16.4% | 6.6% | 2.4% | · |
| BIO | · | · | · | · | · | · |
| BRKR | $7.17B | -314.1 | 2.1% | -0.25% | -0.40% | 45.9% |
| SHC | $5.02B | 65.3 | 5.7% | 6.7% | 14.0% | 55.5% |
| ADPT | $2.50B | -41.6 | 54.8% | -21.5% | -28.2% | · |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 七月 29, 2026 申报